期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
The Changes in the Awareness of Cervical Cancer Prevention and the Acceptability of HPV Vaccines among Women after Their Introduction in China 被引量:5
1
作者 MA Quan Fu GUO Yu Lin +7 位作者 YAN Bin FAN Chun Li XU Meng DAI Xuan WANG Ying ZOU Miao WANG Chao Nan WU Xu Feng 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2019年第11期864-868,共5页
Cervical cancer is a form of malignant tumor that seriously threatens women’s health. In China,according to the cancer statistics, 98,900 new cervical cancer cases and 30,500 deaths due to cervical cancer were estima... Cervical cancer is a form of malignant tumor that seriously threatens women’s health. In China,according to the cancer statistics, 98,900 new cervical cancer cases and 30,500 deaths due to cervical cancer were estimated to have occurred in2015, and the incidence and mortality rates still exhibited an upward trend[1]. 展开更多
关键词 HPV The Changes in the Awareness of Cervical Cancer prevention and the Acceptability of HPV Vaccines among Women after Their Introduction in China China
下载PDF
我国疫苗可预防性疾病一级预防服务能力分析 被引量:1
2
作者 龚裕卿 施培武 +14 位作者 沈群红 张朝阳 陈政 蒲川 徐凌忠 胡志 马安宁 龚朝晖 徐天强 王磐石 汪华 郝超 李程跃 周庆誉 郝模 《中国卫生资源》 北大核心 2022年第2期145-149,153,共6页
目的 分析2019年我国31个省(自治区、直辖市)和东、中、西部疫苗可预防性疾病(vaccine preventable disease,VPD)一级预防服务能力水平、2004—2019年的变化趋势及其与发病率的关系,为提升预防服务能力,究善VPDs防控工作提供参考。方法... 目的 分析2019年我国31个省(自治区、直辖市)和东、中、西部疫苗可预防性疾病(vaccine preventable disease,VPD)一级预防服务能力水平、2004—2019年的变化趋势及其与发病率的关系,为提升预防服务能力,究善VPDs防控工作提供参考。方法 收集31个省(自治区、直辖市)2004—2019年所有涉及VPDs的法律法规和政策等公开文件,基于文本分析方法量化计算一级预防服务能力和变化趋势,并运用相关分析检验其与VPDs发病率的相关性。结果 2019年我国VPDs一级预防服务能力达到57.02%,与2004年相比增长61.44%,但健康教育、疾病和危险因素监测、危险因素控制或行为干预的服务可考核率仅为40.80%、29.98%、18.60%;东、中、西部地区VPDs一级预防服务能力分别为69.09%、52.15%、49.19%,东部服务覆盖程度与可考核程度均超过中、西部;我国层面的VPDs一级预防服务能力与发病率之间呈现负相关(r=-0.693,P<0.01)。结论 2004年以来我国VPDs一级预防服务能力具有提升,但是各地区之间能力存在差异,进一步提升VPDs预防服务能力需要“扩面”与“提质”兼顾。 展开更多
关键词 疫苗可预防性疾病vaccine preventable disease VPD 一级预防primary prevention 服务能力capacity of service 文本分析content analysis 中国China
下载PDF
Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management 被引量:10
3
作者 Petra Bogovic Franc Strle 《World Journal of Clinical Cases》 SCIE 2015年第5期430-441,共12页
Tick-borne encephalitis is an infection of central nervous system caused by tick-borne encephalitis virus transmitted to humans predominantly by tick bites. During the last few decades the incidence of the disease has... Tick-borne encephalitis is an infection of central nervous system caused by tick-borne encephalitis virus transmitted to humans predominantly by tick bites. During the last few decades the incidence of the disease has been increasing and poses a growing health problem in almost all endemic European and Asian countries. Most cases occur during the highest period of tick activity, in Central Europe mainly from April to November. Tickborne encephalitis is more common in adults than in children. Clinical spectrum of the disease ranges from mild meningitis to severe meningoencephalitis with or without paralysis. Rare clinical manifestations are an abortive form of the disease and a chronic progressive form. A post-encephalitic syndrome, causing long-lasting morbidity that often affects the quality of life develops in up to 50% of patients after acute tick-borne encephalitis. Clinical course and outcome vary by subtype of tick-borne encephalitis virus(the disease caused by the European subtype has milder course and better outcome than the disease caused by Siberian and Far-Easter subtypes), age of patients(increasing age is associated with less favorable outcome), and host genetic factors. Since clinical features and laboratory results of blood and cerebrospinal fluid are nonspecific, the diagnosis must be confirmed by microbiologic findings. The routine laboratory confirmation of the tick-borne encephalitis virus infection is based mainly on the detection of specific Ig M and Ig G antibodies in serum(and cerebrospinal fluid), usually by enzyme-linked immunosorbent assay. There is no specific antiviral treatment for tick-borne encephalitis. Vaccination can effectively prevent the disease and is indicated for persons living in or visiting tick-borne encephalitis endemic areas. 展开更多
关键词 TICK-BORNE ENCEPHALITIS Diagnosis EPIDEMIOLOGY Clinical MANIFESTATIONS Treatment prevention/vaccination
下载PDF
The prevalence,origin,and prevention of six human coronaviruses
4
作者 Lanlan Liu Tao Wang Jiahai Lu 《Virologica Sinica》 SCIE CAS CSCD 2016年第1期94-99,共6页
CORONAVIRUSES Coronaviruses(CoVs)are a large group of viruses found in many species of animals around the world,particularly bats and wild birds.CoVs result in various clinical manifestations ranging from asymptomat... CORONAVIRUSES Coronaviruses(CoVs)are a large group of viruses found in many species of animals around the world,particularly bats and wild birds.CoVs result in various clinical manifestations ranging from asymptomatic respiratory,hepatic, 展开更多
关键词 prevalence birds enteric origin prevention vaccines asymptomatic reservoir sequenced younger
原文传递
Recent advances in synthetic carbohydrate-based human immunodeficiency virus vaccines 被引量:2
5
作者 Zhenyuan Wang Chunjun Qin +2 位作者 Jing Hu Xiaoqiang Guo Jian Yin 《Virologica Sinica》 SCIE CAS CSCD 2016年第2期110-117,共8页
An effective vaccine for human immunodeficiency virus(HIV) is urgently needed to prevent HIV infection and progression to acquired immune deficiency syndrome(AIDS). As glycosylation of viral proteins becomes better un... An effective vaccine for human immunodeficiency virus(HIV) is urgently needed to prevent HIV infection and progression to acquired immune deficiency syndrome(AIDS). As glycosylation of viral proteins becomes better understood, carbohydrate-based antiviral vaccines against special viruses have attracted much attention. Significant efforts in carbohydrate synthesis and immunogenicity research have resulted in the development of multiple carbohydrate-based HIV vaccines. This review summarizes recent advances in synthetic carbohydrate-based vaccines design strategies and the applications of these vaccines in the prevention of HIV. 展开更多
关键词 vaccines carbohydrate advances antiviral epitope vaccination antiretroviral antigenic prevention understood
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部